Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults

O. M. Koc, P. H. M. Savelkoul, I. H. M. van Loo, A. Peeters, A. M. L. Oude Lashof*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1048-1056
Number of pages9
JournalJournal of Viral Hepatitis
Volume25
Issue number9
DOIs
Publication statusPublished - Sep 2018

Keywords

  • adjuvant
  • HBAI20
  • Hepatitis B
  • immunogenicity
  • nonresponder
  • safety
  • vaccine
  • CONTROLLED CLINICAL-TRIAL
  • CHRONIC UREMIC PATIENTS
  • LOW-DOSE INTERLEUKIN-2
  • T-CELL-ACTIVATION
  • RECOMBINANT INTERLEUKIN-2
  • DENDRITIC CELLS
  • SURFACE-ANTIGEN
  • INFLUSOME-VAC
  • DIFFERENTIATION
  • EFFICACY

Cite this